Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 286
Filter
1.
J Biochem ; 142(5): 571-6, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17846062

ABSTRACT

Semicarbazide-sensitive amine oxidase (SSAO) is a multifunctional enzyme with different biological roles that depend on the tissue where it is expressed. Because SSAO activity is altered in several pathological conditions, we were interested in studying the possible regulation of the human enzyme activity. It has been previously reported that SSAO activity is increased in the presence of Dulbecco's modified Eagle medium (DMEM) in vitro. The aim of the present work was to investigate the effects of the different constituents of DMEM on human SSAO activity. We found that sodium bicarbonate was the only component able to mimic the enhancement of both human aorta and plasma SSAO activity in vitro, suggesting a possible physiological role of bicarbonate as an intrinsic modulator of the human enzyme. Failure to take this activating effect into account could also result in inaccuracies in the reported tissue activities of this enzyme.


Subject(s)
Amine Oxidase (Copper-Containing)/drug effects , Cell Adhesion Molecules/metabolism , Cell Membrane/metabolism , Culture Media , Sodium Bicarbonate/pharmacology , Amine Oxidase (Copper-Containing)/metabolism , Blotting, Northern , Enzyme Activation , Humans , Solubility
2.
J Neural Transm (Vienna) ; 114(6): 787-91, 2007.
Article in English | MEDLINE | ID: mdl-17401530

ABSTRACT

The monooxygenases and the amine oxidases (AOs) are the major enzyme systems involved in vivo in the oxidative metabolism of xenobiotic amines in humans. With the exception of the inhibition of the metabolism of tyramine ingested by subjects taking inhibitors of MAO-A or of both MAO-A and -B, which has been extensively investigated, the involvement of the monoamine oxidases in xenobiotic amine metabolism (drugs in particular) has been largely neglected. Furthermore, with the exception of amlodipine, there have been essentially no studies on the metabolism of drug amines by amine oxidases such as SSAOs and PAOs in humans. In contrast, monooxygenases (CYP isoenzymes, and to a lesser extent, FMOs) have been extensively investigated in terms of their involvement in xenobiotic metabolism. It is possible that the contribution of AOs to the overall metabolism of xenobiotic amines in humans has been underestimated, or erroneously estimated, as most investigations of drug metabolism have been performed using in vitro test systems optimized for CYP activity, such as liver microsomes, and most investigations of drug metabolism in vivo in humans have identified only the final, stable metabolites.


Subject(s)
Amines/metabolism , Aryl Hydrocarbon Hydroxylases/metabolism , Inactivation, Metabolic/physiology , Monoamine Oxidase/metabolism , Amine Oxidase (Copper-Containing)/metabolism , Cytochrome P-450 Enzyme System/metabolism , Humans , Microsomes, Liver/enzymology , Oxygenases/metabolism
3.
J Neural Transm (Vienna) ; 114(6): 751-6, 2007.
Article in English | MEDLINE | ID: mdl-17401531

ABSTRACT

Semicarbazide-sensitive amine oxidase (SSAO) also functions as a vascular-adhesion protein (VAP-1). The nature of the target site on lymphocytes to which endothelial-cell SSAO/VAP-1 binds is unknown. We have shown that amino sugars (galactosamine, glucosamine and mannosamine), which are not SSAO substrates, can bind to the enzyme as reversible inhibitors. Thus, they serve as a model system in which to study the interaction process. Binding occurred during substrate (benzylamine) oxidation but not when the amino sugar was incubated, for extended periods, with SSAO alone. These results suggest that one, or more of the products of the SSAO-catalysed amine oxidation might be necessary for the inhibitory process to occur. Two of the reaction products of benzylamine oxidation, benzaldehyde and ammonia were found to have no effect on the inhibition of SSAO by galactosamine. Preincubation of the enzyme with galactosamine plus H(2)O(2) was, however, found to result in time-dependent inhibition. This is not a result of the non-enzymic reaction between H(2)O(2) and the amino sugar, since preincubation of galactosamine with H(2)O(2) alone, for extended periods, did not give rise to an inhibitory species. The amount of exogenously added H(2)O(2) necessary for inhibition was very much greater than that formed during substrate oxidation. These results suggest that the H(2)O(2) formed as a product of the SSAO-catalysed oxidation reaction is more efective in promoting the binding of amino sugars.


Subject(s)
Amine Oxidase (Copper-Containing)/metabolism , Amines/metabolism , Amino Sugars/metabolism , Cell Adhesion Molecules/metabolism , Hydrogen Peroxide/metabolism , Amine Oxidase (Copper-Containing)/chemistry , Amine Oxidase (Copper-Containing)/drug effects , Amines/chemistry , Amino Sugars/chemistry , Animals , Benzylamines/chemistry , Benzylamines/metabolism , Catalytic Domain/drug effects , Catalytic Domain/physiology , Cattle , Cell Adhesion Molecules/chemistry , Cell Adhesion Molecules/drug effects , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/metabolism , Enzyme Inhibitors/pharmacology , Galactosamine/chemistry , Galactosamine/metabolism , Hydrogen Peroxide/chemistry , Hydrogen Peroxide/pharmacology , Oxidation-Reduction , Protein Binding/drug effects , Protein Binding/physiology
4.
J Neural Transm (Vienna) ; 114(6): 775-6, 2007.
Article in English | MEDLINE | ID: mdl-17385068

ABSTRACT

Recently, a new FAD-dependent amine oxidase, renalase, was described. It was secreted by the kidney into the blood and shown to have significant cardiovascular actions, which were attributed to its catecholamine-metabolising activity. The authors concluded that renalase might be an important regulatory factor in human (patho)physiology. The catecholamine-metabolising activity of renalase in plasma contrasts with previous investigations where catecholamines were found to be stable in human plasma, provided autoxidation is prevented by an antioxidant. The claim of catecholamine-metabolising activity of renalase was based on the generation of H(2)O(2) during incubation of the enzyme with catecholamines. Careful inspection and calculations of the data lead to the conclusion that the rate of H(2)O(2) generation is far too low to be ascribed to enzymatic conversion of catecholamines by renalase. Renalase may well have important cardiovascular functions, but there is no proof that its actions are mediated through catecholamine-metabolising activity.


Subject(s)
Catecholamines/metabolism , Kidney/enzymology , Monoamine Oxidase/metabolism , Animals , Cardiovascular Physiological Phenomena , Cardiovascular System/innervation , Cardiovascular System/metabolism , Humans , Hydrogen Peroxide/metabolism , Monoamine Oxidase/chemistry , Monoamine Oxidase/isolation & purification
7.
Neurochem Res ; 29(1): 325-34, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14992293

ABSTRACT

The concentrations of endogenous amino acids and choline in the extracellular fluid of human cerebral gliomas have been measured, for the first time, by in vivo microdialysis. Glioblastoma growth was associated with increased concentrations of choline, GABA, isoleucine, leucine, lysine, phenylalanine, taurine, tyrosine, and valine. There was no difference between grade III and grade IV tumors in the concentrations of phenylalanine, isoleucine, tyrosine, valine, and lysine, whereas the concentrations of choline, aspartate, taurine, GABA, leucine, and glutamate were significantly different in the two tumor-grade subgroups. In contrast to the other compounds, the concentration of glutamate was decreased in glioma. The parenchyma adjacent to the tumor showed significant changes only in the extracellular concentration of glutamate, isoleucine, and valine. The concentrations of choline and the amino acids, glutamate, leucine, taurine, and tyrosine showed significant positive correlations with the degree of cell proliferation. Epilepsy, which is relatively common in subjects with gliomas, was shown to be a significant confounding variable when the extracellular concentrations of aspartate, glutamate and GABA were considered.


Subject(s)
Amino Acids/metabolism , Brain Neoplasms/metabolism , Choline/metabolism , Glioma/metabolism , Adult , Aged , Brain Neoplasms/pathology , Brain Neoplasms/surgery , Cell Division , Extracellular Space/metabolism , Female , Glioma/pathology , Glioma/surgery , Humans , Intraoperative Period , Male , Microdialysis , Middle Aged
8.
Br J Cancer ; 89(10): 1979-86, 2003 Nov 17.
Article in English | MEDLINE | ID: mdl-14612913

ABSTRACT

l-Deprenyl (R-(-)-deprenyl, selegiline) is an inhibitor of monoamine oxidase-B (MAO-B) that is known to protect nerve cells from a variety of chemical and physical insults. As apoptosis is a common mechanism of radiation-induced cell death, the effect of l-deprenyl on the survival of cultured cells and tissue explants was studied following exposure to gamma radiation. The results obtained were compared with the effects of the less-selective MAO-B inhibitor pargyline and the MAO-A inhibitor clorgyline. l-Deprenyl at a concentration of 10(-9) M protected the nontumorigenic cell line (HaCaT) and normal human urothelial explants from the effects of cobalt-60 gamma radiation, but did not protect tumorigenic human cell lines HaCaT-ras, HPV-transfected human keratinocytes (HPV-G cells), or PC3. Human bladder carcinoma explants were not protected. Clorgyline showed a smaller protective effect of normal cells, whereas pargyline had no effect. Radiation-induced delayed effects (genomic instability measured as delayed cell death) were prevented in normal cells by l-deprenyl but, interestingly, deprenyl appeared to increase the amount of delayed death in the tumorigenic cell lines. Studies using l-deprenyl prior to the exposure of nonmalignant cells to cisplatin showed that cell death due to this agent was also reduced. Treatment of cultures of nontumorigenic cells with l-deprenyl or clorgyline significantly increased the levels of the protein Bcl-2 following irradiation, but there was no such effect on the already-elevated levels of this protein in the tumour samples. Since the Bcl-2 has been shown to be an inhibitor of apoptosis or programmed cell death, this would imply that the protective effects of l-deprenyl and clorgyline involve activation of antiapoptotic pathways within the normal cell. This hypothesis is supported by data showing reduced levels of apoptosis in HaCAT cells and in normal bladder explant cultures following treatment with l-deprenyl.


Subject(s)
Antineoplastic Agents/adverse effects , Apoptosis , Cell Transformation, Neoplastic , Clorgyline/pharmacology , Gamma Rays/adverse effects , Monoamine Oxidase Inhibitors/pharmacology , Selegiline/pharmacology , Animals , Cell Culture Techniques , Cell Survival , Humans , Mice , Radiation-Protective Agents/pharmacology , Tumor Cells, Cultured , Urinary Bladder/cytology
9.
Biochim Biophys Acta ; 1638(3): 278-86, 2003 Jul 30.
Article in English | MEDLINE | ID: mdl-12878330

ABSTRACT

Semicarbazide-sensitive amine oxidase (SSAO) encodes a wide family of enzymes named E.C.1.4.3.6 [amine:oxygen oxidoreductase (deaminating) (copper containing)] that metabolises primary aliphatic and aromatic amines. It is present in almost all vascularised and nonvascularised mammalian tissues, and it is also present in soluble form in plasma. SSAO appears to show different functions depending on the tissue where it is expressed. Here we describe, for the first time, the activation of the SSAO from human lung by human plasma. The extent of activation was greater when the human plasma came from diabetic and heart infarcted patients. A kinetic mechanism of such effect is proposed. The activation was lost after the plasma was dialysed, indicating a low molecular weight component (MW <3800 Da) to be responsible. The activator component is heat stable and resistant to proteolysis by chymotrypsin and trypsin and also resistant to perchloric acid treatment. However, treatment with 35% formic acid, completely abolished activation, suggesting involvement of lipid material. The possibility of that lysophosphatidylcholine (LPC), an amphiphilic phospholipid derived from the phosphatidylcholine, the major component in plasma accumulated in pathological conditions, was studied. LPC was shown to behave as a "competitive activator" of human lung SSAO at concentrations below its critical micellar concentration (CMC value=50 microM). Thus LPC may be a component of the SSAO activatory material present in human plasma.


Subject(s)
Amine Oxidase (Copper-Containing)/metabolism , Lung/enzymology , Phospholipids/metabolism , Amine Oxidase (Copper-Containing)/blood , Amine Oxidase (Copper-Containing)/chemistry , Burns/blood , Diabetes Mellitus/blood , Enzyme Activation/drug effects , Enzyme Stability , Humans , Hydrogen-Ion Concentration , In Vitro Techniques , Kinetics , Lung/drug effects , Lysophosphatidylcholines/pharmacology , Myocardial Infarction/blood , Phospholipids/blood
10.
J Neurochem ; 86(4): 1032-41, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12887700

ABSTRACT

Synaptosomes, isolated from the whole brain of young (3 months) and old (24 months) rats were used to study the major bioenergetic systems of neuronal mitochondria in situ, within the synaptosome. Approximately 85% of the resting oxygen consumption of synaptosomes from both young and old rats was a result of proton leak (and possibly other ion cycling) across the mitochondrial inner membrane. There were no significant differences between synaptosomes from the young and old rats in the kinetic responses of the substrate oxidation system, the mitochondrial proton leak and the phosphorylation system to changes in the proton electrochemical gradient. Flux control coefficients of 0.71, 0.27 and 0.02 were calculated for substrate oxidation system, phosphorylation system and the proton leak, respectively, at maximal ATP producing capacity in synaptosomes from young animals. The corresponding values calculated for synaptosomes from old animals were 0.53, 0.43 and 0.05. Thus substrate oxidation had greatest control over oxygen consumption at maximal phosphorylating capacity for synaptosomes from whole brain, with proton leak, having little control under maximal ATP producing capacity. The uncoupled rate of oxygen consumption, in the presence of the mitochondrial uncoupler, carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP), was significantly lower (p = 0.0124) in synaptosomes from old rats (6.08 +/- 0.42, n = 11) when compared with those from the young rats (7.87 +/- 0.48, n = 8). Thus, there is an impaired flux through the substrate oxidation system is synaptosomes from old rats, as compared to synaptosomes from the young animals. These in situ results may have important implications for the interpretation of theories that age-dependent impairment of mitochondrial energy production may result in increased susceptibility to neurodegeneration.


Subject(s)
Brain/metabolism , Mitochondria/metabolism , Oxidative Phosphorylation , Synaptosomes/metabolism , Age Factors , Animals , Brain Chemistry , Kinetics , Male , Membrane Potentials/physiology , Mitochondria/chemistry , Oxidation-Reduction , Oxygen Consumption/physiology , Rats , Rats, Wistar , Synaptosomes/chemistry
11.
Biochem Soc Trans ; 31(Pt 3): 711-5, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12773189

ABSTRACT

It is becoming increasingly apparent that many well-known enzymes have alternative non-enzymic functions. Similarly, several proteins that were identified as having non-catalytic functions were subsequently found to have enzyme activities. Some examples are considered to illustrate the diversity of alternative functions. The semicarbazide-sensitive amine oxidase (EC 1.4.3.6) is considered in more depth as an example. It was originally believed to be a detoxifying enzyme, but the reaction products may have important signalling functions. Furthermore, this enzyme, from some sources, also behaves as a vascular-adhesion protein. Finally, the challenges posed by such multiplicity of functions for the interpretation of genetic deletion, in vivo inhibition and the development of functional protein databases are briefly considered.


Subject(s)
Amine Oxidase (Copper-Containing)/metabolism , Cells/enzymology , Enzymes/metabolism , Catalysis , Enzymes/classification , Humans , Kinetics , Models, Biological
12.
Amino Acids ; 23(4): 367-79, 2002.
Article in English | MEDLINE | ID: mdl-12436204

ABSTRACT

Despite the multitude of evidence for the beneficial effects of taurine supplementation in a variety of disease, the underlying modifying action of taurine with respect to either molecular or biochemical mechanisms is almost totally unknown. We have assessed the development of taurine analogues, particularly where there has been substitution at the suphonate or amine group. Such substitutions allow the investigator to probe the relationship between structure and function of the taurine molecule. In addition such studies should help to ascertain taurine's point of interaction with the effector molecule. These results will prepare the way for the development of the second generation of taurine analogues.


Subject(s)
Taurine/analogs & derivatives , Taurine/metabolism , Animals , Calcium/metabolism , Ethanol/metabolism , Homeostasis , Humans , Molecular Structure , Muscle Contraction/physiology , Neurotransmitter Agents/chemistry , Neurotransmitter Agents/metabolism , gamma-Aminobutyric Acid/metabolism
13.
J Neural Transm (Vienna) ; 109(5-6): 585-96, 2002 May.
Article in English | MEDLINE | ID: mdl-12111451

ABSTRACT

The possible protection against the toxicity of 1-methyl-4-phenylpyridinium (MPP(+)) afforded by inhibitors of nitric oxide synthase (NOS) and the antagonist of N-methyl-D-aspartate receptor function, MK-801, was studied in a brain-slice superfusion system. Significant decreases in levels of dopamine and its metabolites 3,4-dihyroxyphenylacetic acid (DOPAC) and homovanillic acid were observed following incubation of slices with 25 microM MPP(+). The activity of intracellular lactate dehydrogenase (LDH), a marker of cell viability, was also significantly decreased. These effects were attenuated by preincubation with I mM 7-nitroindazole (7NI), a selective inhibitor of the neuronal isoform of nitric oxide synthase (NOS). In contrast, the nonspecific NOS inhibitor N(omega)-nitro-L-arginine, also at 1 mM, had no effect on levels of dopamine metabolites but did show a small attenuation of the levels of dopamine. 7NI alone caused some increase in levels of dopamine and a decrease in the metabolite DOPAC, which is consistent with it also acting as an inhibitor of monoamine oxidase-B. MK-801 afforded no significant protection of aminergic cells, although changes in LDH activity suggested that there may have been some protection of non-aminergic neurons affected by this, relatively high concentration of MPP(+).


Subject(s)
1-Methyl-4-phenylpyridinium/antagonists & inhibitors , 1-Methyl-4-phenylpyridinium/poisoning , Enzyme Inhibitors/pharmacology , Nitric Oxide Synthase/antagonists & inhibitors , 3,4-Dihydroxyphenylacetic Acid/metabolism , Animals , Brain/drug effects , Brain/metabolism , Dizocilpine Maleate/pharmacology , Excitatory Amino Acid Antagonists/pharmacology , Female , Homovanillic Acid/metabolism , In Vitro Techniques , Indazoles/pharmacology , L-Lactate Dehydrogenase/metabolism , Nitric Oxide Synthase Type I , Nitroarginine/pharmacology , Rats , Rats, Wistar
14.
Parkinsonism Relat Disord ; 8(4): 247-53, 2002 Mar.
Article in English | MEDLINE | ID: mdl-12039419

ABSTRACT

Rats were injected intraperitoneally with varying doses of l-deprenyl (selegiline) followed 2h later by 30 mg kg(-1) 2-phenylethylamine (PEA), administered in the same way, and the stereotypic behavioural response elicited was assessed. l-Deprenyl alone at doses of up to 5 mg kg(-1) caused no significant behavioural response. Administration of PEA without prior l-deprenyl treatment resulted in only a modest increase in stereotypic behaviour and this was not significantly enhanced by the prior administration 1 mg kg(-1) l-deprenyl. When the administered dose of l-deprenyl was increased to 2.5 or 5 mgkg(-1), however, the stereotypic behavioural response to PEA was greatly potentiated and in the latter case persisted for 60 min. A dose of 2.5 mg kg(-1) l-deprenyl and 1 mg kg(-1) rasagiline was shown to result in over 90% inhibition of the monoamine oxidase (MAO)-B from rat liver and striatum, whereas the inhibition of MAO-A was about 60 and 40% in liver and striatum, respectively. The recovery of MAO-B activity in rat striatum and liver following a single i.p. injection of 5 mg kg(-1) l-deprenyl gave first-order rate constants of 1.80 and 7.15 h(-1), respectively, which corresponded to half-lives of 9.23 and 2.33 days. Similar results were obtained with rasagiline. The corresponding indices of stereotypic response to PEA (30 mg kg(-1); i.p.) during recovery from the single dose of l-deprenyl were initially high, but had started to decline by the third day after l-deprenyl treatment and was not significant after day 4. At that time, less than 20% of the striatal monoamine oxidase-B activity had been regained, whereas the recovery of the liver enzyme was about 65%. These data are discussed in terms of the suggested involvement of PEA potentiation in the anti-parkinsonian actions of l-deprenyl and rasagiline and the duration of the 'wash-out' period used in studies on the effects of l-deprenyl on patients with Parkinson's disease. The longer duration of the recovery of brain monoamine oxidase B after its selective inhibition and the corresponding behavioural responses of the animals to PEA at same time points, indicate that PEA may have a major pharmacological role in the mechanism of the antiParkinson action of l-deprenyl and rasagiline. Brain monoamine oxidase B inhibition has previously been shown to significantly increases brain PEA and which is capable of releasing dopamine endogenously or that formed from L-dopa.


Subject(s)
Corpus Striatum/enzymology , Indans/pharmacology , Monoamine Oxidase Inhibitors/pharmacology , Monoamine Oxidase/drug effects , Selegiline/pharmacology , Animals , Behavior, Animal/drug effects , Dose-Response Relationship, Drug , Drug Synergism , Indans/administration & dosage , Male , Monoamine Oxidase Inhibitors/administration & dosage , Parkinson Disease, Secondary/chemically induced , Phenethylamines/pharmacology , Psychotropic Drugs/pharmacology , Rats , Rats, Sprague-Dawley , Selegiline/administration & dosage , Stereotyped Behavior
15.
Arch Oral Biol ; 47(5): 399-406, 2002 May.
Article in English | MEDLINE | ID: mdl-12015221

ABSTRACT

The semicarbazide-sensitive amine oxidase (EC 1.4.3.6; SSAO) from crude homogenates of human dental pulp was shown to catalyse the oxidative deamination of 5-hydroxytryptamine (serotonin; 5-HT) with a K(m) of 318+/-52 microM. In this respect the human enzyme resembles that in pig dental pulp, but differs from SSAO in all other tissues studied, which are inactive towards 5-HT. A method is described for obtaining intact dental pulp in which the anatomical details are preserved. Extracted teeth are frozen in dry ice and later defrosted rapidly before being fractured in a mechanical vice, facilitating pulp removal. Immunohistochemistry showed SSAO in the odontoblast layer, nerve fibres and blood vessels. The presence of SSAO in nerves in dental pulp appears to be unique. Tryptophan hydroxylase, a key enzyme in 5-HT synthesis, was also demonstrated in nerves and the odontoblast layer of human dental pulp.


Subject(s)
Amine Oxidase (Copper-Containing)/metabolism , Dental Pulp/enzymology , Serotonin/metabolism , Benzylamines/metabolism , Blotting, Western , Deamination , Dental Pulp/cytology , Dental Pulp/innervation , Freeze Fracturing , Humans , Immunohistochemistry , Monoamine Oxidase/metabolism , Odontoblasts/enzymology , Tryptophan Hydroxylase/analysis
16.
J Neural Transm (Vienna) ; 109(3): 251-65, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11956949

ABSTRACT

The specific activity and kinetic behaviour of semicarbazide-sensitive amine oxidase (EC 1.4.3.6; SSAO) towards benzylamine, in the rat heart, is affected by in vivo treatment with the non-selective monoamine oxidase (MAO) inhibitor tranylcypromine, but not by the selective MAO-A and -B inhibitors, clorgyline and lazabemide. SSAO activity was increased to 178% of control activity after 7 days of treatment with tranylcypromine. This increase appears to represent an increase in the limiting velocity (V(max)) for benzylamine oxidation with no significant change in the K(m) at that time-point. However, the K(m) for benzylamine oxidation was found to decrease in both controls and treated groups, in a time-dependent manner, during the treatment regime. These findings suggest a link between SSAO and cellular stress and may have importance in the context of the recent finding that tissue-SSAO is identical to a vascular adhesion protein (VAP1), involved in the process of inflammation.


Subject(s)
Amine Oxidase (Copper-Containing)/metabolism , Brain/enzymology , Heart/physiology , Liver/enzymology , Monoamine Oxidase Inhibitors/pharmacology , Monoamine Oxidase/metabolism , Myocardium/enzymology , Amine Oxidase (Copper-Containing)/drug effects , Animals , Brain/drug effects , Clorgyline/pharmacology , Dopamine/metabolism , Female , Heart/drug effects , Kinetics , Liver/drug effects , Monoamine Oxidase/drug effects , Picolinic Acids/pharmacology , Rats , Rats, Sprague-Dawley , Serotonin/metabolism , Subcellular Fractions/drug effects , Subcellular Fractions/metabolism , Tranylcypromine/pharmacology
17.
Int Endod J ; 35(1): 47-55, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11853238

ABSTRACT

AIM: This work was designed to investigate the potential cytotoxicity of two of the newer dental restorative materials. Spectrum composite resin and Dyract AP compomer. METHODOLOGY: Cultured human endothelial cells (ECV-304) were exposed to each of the restorative materials through a 70-microm dentine barrier to simulate the in vivo clinical situation. Cell viability was measured by the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyltetrazolium bromide) assay and lactate dehydrogenase release assay. The effects of different extents of light-curing were also examined by microscopic examination of stained human promyelocytic leukemia cells (HL-60). Caspase-3 activation was determined as a measure of apoptotic cell death. RESULTS: Assessment of cellular viability indicated that both materials cause cell death, with Spectrum being the more toxic. The cytotoxicity was considerably increased in the absence of the dentine barrier. Direct exposure to Spectrum for 12 h resulted in the death of 69% of the cells after full light-curing (78% of total death was by apoptosis) and 96% after partial light-curing (73% of total death was by necrosis). Assessment of caspase activation, in the absence of the dentine barrier, showed that longer curing-times resulted in an increase in the proportion of the cells dying through apoptosis, rather than necrosis, for both materials tested. CONCLUSIONS: These results indicate the restorative materials to be potentially toxic, particularly if the degree of light-cure is inadequate.


Subject(s)
Compomers/toxicity , Composite Resins/toxicity , Dental Materials/toxicity , Apoptosis/drug effects , Caspase 3 , Caspases/analysis , Cell Death/drug effects , Cell Survival/drug effects , Cells, Cultured , Coloring Agents , Compomers/chemistry , Composite Resins/chemistry , Dental Materials/chemistry , Dentin , Endothelium/cytology , Endothelium/drug effects , Enzyme Precursors/analysis , Humans , L-Lactate Dehydrogenase/analysis , Leukemia, Promyelocytic, Acute/pathology , Light , Materials Testing , Methacrylates/chemistry , Methacrylates/toxicity , Necrosis , Pilot Projects , Silicates/chemistry , Silicates/toxicity , Statistics as Topic , Tetrazolium Salts , Thiazoles
18.
Brain Res Bull ; 55(2): 239-45, 2001 May 15.
Article in English | MEDLINE | ID: mdl-11470322

ABSTRACT

The neurotoxin 6-hydroxydopamine was shown to cause an imbalance between the direct and indirect pathways of the striato-nigral system as evidenced by a decreased release of gamma-aminobutyric acid and taurine in the substantia nigra but not in the globus pallidus following neostriatal stimulation with kainate (100 microM). The neurotoxicity of 6-hydroxydopamine is generally believed to result from reactive-oxygen radical formation, although it is also known to inhibit mitochondrial NADH dehydrogenase. The release of Fe(II) from the unactivated form [3Fe(III)-4S] of cytoplasmic aconitase (EC(50) < 8 microM) was shown to be followed by the slower oxidation of thiol groups in the protein. Complete loss of -SH groups, and enzyme activity, was seen after incubation of glyceraldenyde-3-phosphate dehydrogenase with 200 microM 6-hydroxydopamine for 75 min at 37 degrees C (IC(50) = 70.8 +/- 0.3 microM). Thus the cellular effects of 6-hydroxydopamine are complex, involving impairment of mitochondrial function, iron- release, sulphydryl-group oxidation, and enzyme inhibition in addition to direct generation of reactive oxygen radicals. Taurine, which is known to be neuroprotective in some other systems, only affords protection against some of these effects, thereby explaining its reported ineffectiveness against 6-hydroxydopamine toxicity.


Subject(s)
Adrenergic Agents/toxicity , Neurons/drug effects , Neuroprotective Agents/pharmacology , Neurotoxins/toxicity , Oxidopamine/toxicity , Taurine/pharmacology , Aconitate Hydratase/drug effects , Aconitate Hydratase/metabolism , Adrenergic Agents/pharmacokinetics , Animals , Dopamine/metabolism , Dopamine/pharmacology , Extracellular Space/drug effects , Extracellular Space/metabolism , Globus Pallidus/drug effects , Globus Pallidus/metabolism , Iron/metabolism , Kainic Acid/pharmacology , Male , Microdialysis , Neostriatum/drug effects , Neostriatum/metabolism , Neural Pathways/drug effects , Neural Pathways/metabolism , Neurons/metabolism , Neuroprotective Agents/metabolism , Neurotoxins/pharmacokinetics , Oxidation-Reduction/drug effects , Oxidopamine/pharmacokinetics , Parkinson Disease/etiology , Parkinson Disease/physiopathology , Presynaptic Terminals/drug effects , Presynaptic Terminals/metabolism , Rats , Rats, Wistar , Substantia Nigra/drug effects , Substantia Nigra/metabolism , Sulfhydryl Compounds/metabolism , Taurine/metabolism , gamma-Aminobutyric Acid/metabolism
19.
Neurotox Res ; 3(4): 397-409, 2001 Aug.
Article in English | MEDLINE | ID: mdl-14715469

ABSTRACT

Excessive oxidative stress has been implicated in the induction of cell death in a variety of neurodegenerative diseases. In the present study, hydrogen peroxide (H2O2)-induced cell death in rat C6 glioma cells was used as a model system for studying the molecular events associated with oxidative stress-induced cell death in glial cells. We demonstrate that exposure of C6 glioma cells to H2O2 results in apoptotic cell death in a concentration-dependent manner, and caused activation of a member of the caspase-3-like family of proteases resulting in cleavage of the DNA repair enzyme poly(ADP-ribose)polymerase, PARP. Furthermore, H2O2 induced a transient activation of the transcription factor, nuclear factor kappa B (NF(Kappa)B). Pre-treatment of cells with the antioxidant N-acetylcysteine, (NAC), prevented both the activation of NF(Kappa)B and the induction of apoptosis by H2O2, suggesting a possible role for this transcription factor in oxidant-induced apoptosis in glial cells. Exposure of the cells to H2O2 led to transient activation of both c-Jun N-terminal kinase (JNK) and p38 kinase but has no effect on extracellular regulated kinase (ERK) activity. Inhibition of p38 by SB203580 did not protect the cells against H2O2-induced apoptosis suggesting that activation of p38 is not essential for H2O2-mediated cell death in C6 glioma cells.

20.
Curr Protoc Pharmacol ; Chapter 3: Unit3.6, 2001 May.
Article in English | MEDLINE | ID: mdl-22293964

ABSTRACT

Monoamine oxidase catalyzes the oxidative deamination of primary aliphatic and aromatic amines and some secondary and tertiary amines, including the hormone and neurotransmitter amines epinephrine, dopamine, norepinephrine and serotonin. The two isoenzymes, MAO-A and MAO-B, differ according to substrate and inhibitor specificities. For example, selective inhibitors of MAO-A have been shown to be effective antidepressants whereas some MAO-B inhibitors have been reported to be beneficial in the treatment of Parkinson's and perhaps Alzheimer's diseases. Thus, it is important to have accurate procedures for determining the activities of each MAO isoenzyme in tissues that may contain both. In this unit, several MAO assay procedures are described, along with support protocols for equilibrating ion-exchange resin, preparing aldehyde dehydrogenase, preparing dose-response curves for determining the relative proportions of isoenzyme activities, determining concentrations of each isoenzyme, assessing new compounds as putative MAO inhibitors, and determining protein concentration of membrane-bound proteins.


Subject(s)
Enzyme Assays/methods , Monoamine Oxidase/metabolism , Radioisotopes , Aldehyde Dehydrogenase/metabolism , Animals , Clorgyline , Epinephrine , Fluorometry/methods , Humans , Hydrogen Peroxide/metabolism , Ion Exchange Resins , Isoenzymes/metabolism , Norepinephrine , Oxidation-Reduction , Oxygen Consumption/physiology , Rats , Selegiline , Spectrophotometry
SELECTION OF CITATIONS
SEARCH DETAIL
...